Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.

ABSTRACT: Based on promising preliminary results from clinical trials, it seems likely that psychedelic substances (classic serotonergic psychedelics, such as psilocybin, and entactogens, such as MDMA) will be introduced into psychiatry as psychedelic-assisted therapy. This also raises a range of ethical questions that urgently need to be addressed before widespread roll-out in society. This scoping review fills a gap in the literature by providing an overview of these ethical issues using a systematic search, presentation, and descriptive analysis of ethical issues in psychedelic-assisted treatments. It includes peer-reviewed studies pertaining to human study participants and psychiatric patients (population), which discuss ethical issues (concept) of psychedelic treatments (context) in clinical tr

SUBMITTER: Caporuscio C 

PROVIDER: S-EPMC12527517 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature